Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
Xconomy
SEPTEMBER 13, 2019
If a medical meeting in Barcelona this week was any indication, more help could be on the way. For decades, advanced lung cancer was a quick death sentence. That’s no longer a given, thanks in part to the arrival of immunotherapy.
Let's personalize your content